Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 61601-61650 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06132035
Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
PHASE1Recruiting
45 participants
Started: Dec 22, 2023 · Completed: Aug 31, 2025
1 condition2 sponsors7 locations
NCT05176210
Safety, Pharmacokinetics, and Food Effect of PS1 in Subjects
PHASE1Recruiting
64 participants
Started: Dec 22, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06065527
Future Planning and Well-Being for Individuals With Intellectual Disabilities and Family Caregivers
NARecruiting
1,050 participants
Started: Dec 22, 2023 · Completed: Apr 30, 2029
1 condition7 sponsors1 location
NCT06139575
Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer
PHASE1/PHASE2Recruiting
90 participants
Started: Dec 22, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor13 locations
NCT06289998
Study of Tamibarotene in Patients With ADPKD
PHASE2Active, not recruiting
70 participants
Started: Dec 22, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor8 locations
NCT06194383
Treatment of Hyperpyrexia and in the Pediatric Emergency Department (FEVER_ED)
N/AActive, not recruiting
160 participants
Started: Dec 22, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06310174
Study Examining the Effect of a Novel Cannulation Knife on User Satisfaction and Common Central Venous Catheter Insertion Complications
N/ARecruiting
144 participants
Started: Dec 22, 2023 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT05927558
Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study
N/ARecruiting
96 participants
Started: Dec 22, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06645236
DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit
NARecruiting
600 participants
Started: Dec 22, 2023 · Completed: Oct 31, 2030
1 condition1 sponsor1 location
NCT06153134
Curcuma Xanthorriza Roxb. 10% Cream for Melasma
EARLY_PHASE1Recruiting
15 participants
Started: Dec 22, 2023 · Completed: May 22, 2024
1 condition1 sponsor1 location
NCT06072053
YL-1 Needle Puncture vs BHC With Postoperative Exhaustive Drainage for CSDH
N/ARecruiting
460 participants
Started: Dec 22, 2023 · Completed: May 1, 2025
1 condition1 sponsor1 location
NCT06026345
Affera Global Registry
N/ARecruiting
540 participants
Started: Dec 22, 2023 · Completed: Jul 1, 2028
1 condition1 sponsor12 locations
NCT04974671
Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma
PHASE2Recruiting
30 participants
Started: Dec 22, 2023 · Completed: Apr 1, 2027
4 conditions1 sponsor1 location
NCT06166082
Stanford Neuromodulation Therapy (SNT) for the Treatment-Resistant Depression
NARecruiting
130 participants
Started: Dec 22, 2023 · Completed: Oct 31, 2024
1 condition6 sponsors5 locations
NCT06298643
Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan
N/AActive, not recruiting
300 participants
Started: Dec 22, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06244277
Chinese Medicine Treatment of Adolescent Sleep Disorders and Sleeping Pills Withdrawal
NARecruiting
106 participants
Started: Dec 22, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06203405
The Efficacy of P0.1-guided Sedation Protocol in Critically Ill Patients Receiving Invasive Mechanical Ventilation: A Randomized Controlled Trial
NARecruiting
214 participants
Started: Dec 22, 2023 · Completed: Jun 30, 2026
5 conditions1 sponsor1 location
NCT05611905
Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid
N/ARecruiting
30 participants
Started: Dec 22, 2023 · Completed: Nov 26, 2027
4 conditions2 sponsors1 location
NCT07045103
A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study
N/ARecruiting
900 participants
Started: Dec 21, 2023 · Completed: May 31, 2026
1 condition8 sponsors7 locations
NCT05572229
Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma
PHASE2Recruiting
74 participants
Started: Dec 21, 2023 · Completed: Sep 30, 2030
1 condition2 sponsors29 locations
NCT06454526
Effects of Mindfulness-Based Program on Individual and Organizational Output of Frontline Manager Nurses:
NAActive, not recruiting
41 participants
Started: Dec 21, 2023 · Completed: Jun 30, 2024
2 conditions1 sponsor1 location
NCT06296121
A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma
PHASE3Recruiting
252 participants
Started: Dec 21, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor14 locations
NCT05280314
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
PHASE2Recruiting
60 participants
Started: Dec 21, 2023 · Completed: Jan 31, 2027
2 conditions4 sponsors15 locations
NCT06205966
A Study to Investigate the Effect of Probiotics (L. Reuteri ATCC PTA 5289 and L. Reuteri DSM 17938) on Symptoms of Viral Upper Respiratory Tract Infections in Children
NARecruiting
142 participants
Started: Dec 21, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06159517
Heart Lung Machine Registry
N/ARecruiting
600 participants
Started: Dec 21, 2023 · Completed: Jun 30, 2025
4 conditions2 sponsors3 locations
NCT06219993
Robot-assisted Modified Kasai Portoenterostomy Versus Open Kasai Portoenterostomy for Biliary Atresia
N/AActive, not recruiting
60 participants
Started: Dec 21, 2023 · Completed: Dec 30, 2025
4 conditions1 sponsor2 locations
NCT06186934
Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea Patients
N/ARecruiting
600 participants
Started: Dec 21, 2023 · Completed: Jan 30, 2026
1 condition1 sponsor1 location
NCT06107738
Iberdomide and Daratumumab As Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
PHASE2Recruiting
60 participants
Started: Dec 21, 2023 · Completed: Dec 31, 2026
1 condition4 sponsors2 locations
NCT05559671
Safety of the Herpes Zoster Subunit Vaccine in Lupus
PHASE4Recruiting
224 participants
Started: Dec 21, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor2 locations
NCT06206135
Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil Capsule
N/ARecruiting
100 participants
Started: Dec 21, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05935202
Safety and Efficacy of Mitapivat Sulfate in Adult Patients With Erythrocyte Membranopathies
PHASE2Not yet recruiting
25 participants
Started: Dec 21, 2023 · Completed: Dec 15, 2026
1 condition1 sponsor2 locations
NCT05892952
IONA Longitudinal Cohort Study
N/ARecruiting
10,000 participants
Started: Dec 21, 2023 · Completed: Dec 21, 2033
2 conditions1 sponsor1 location
NCT06414538
The Effect of Digital Mind Map and Midwifery Students
NARecruiting
80 participants
Started: Dec 21, 2023 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT06119581
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
PHASE3Recruiting
1,016 participants
Started: Dec 21, 2023 · Completed: Oct 31, 2029
2 conditions1 sponsor428 locations
NCT06122662
AMX0035 and Progressive Supranuclear Palsy
PHASE2/PHASE3Active, not recruiting
110 participants
Started: Dec 21, 2023 · Completed: Nov 30, 2029
4 conditions1 sponsor62 locations
NCT06114108
Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients
NARecruiting
128 participants
Started: Dec 21, 2023 · Completed: Nov 1, 2027
2 conditions1 sponsor7 locations
NCT06498219
Optimization of the Skin Test Procedure With Iodinated Contrast Products for Certain Patients Suspected of Immediate Hypersensitivity
N/ARecruiting
100 participants
Started: Dec 21, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06015672
Accelerated TMS for Focal Hand Dystonia
NARecruiting
20 participants
Started: Dec 21, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06012045
Enhanced Cue Exposure Therapy for Negative Emotional Eating
NARecruiting
138 participants
Started: Dec 21, 2023 · Completed: Mar 2, 2026
2 conditions1 sponsor1 location
NCT06056830
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
PHASE3Recruiting
383 participants
Started: Dec 21, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor23 locations
NCT05292521
Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer
NARecruiting
150 participants
Started: Dec 21, 2023 · Completed: Dec 21, 2028
9 conditions2 sponsors1 location
NCT06140836
A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)
PHASE3Active, not recruiting
190 participants
Started: Dec 21, 2023 · Completed: Jun 3, 2027
1 condition2 sponsors122 locations
NCT05776953
Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients
PHASE4Recruiting
86 participants
Started: Dec 21, 2023 · Completed: Feb 28, 2026
4 conditions1 sponsor1 location
NCT06157086
Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in France
N/ARecruiting
294 participants
Started: Dec 21, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor43 locations
NCT06011876
BioFLO for Respiratory Recovery in SCI
NARecruiting
62 participants
Started: Dec 21, 2023 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT06181435
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)
PHASE3Active, not recruiting
589 participants
Started: Dec 21, 2023 · Completed: Mar 17, 2026
1 condition1 sponsor142 locations
NCT06104618
Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis
PHASE2Recruiting
28 participants
Started: Dec 21, 2023 · Completed: Nov 1, 2026
4 conditions1 sponsor3 locations
NCT06151847
Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma
PHASE2Recruiting
12 participants
Started: Dec 21, 2023 · Completed: Nov 27, 2025
4 conditions3 sponsors1 location
NCT06336239
PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study
N/ARecruiting
3,000 participants
Started: Dec 21, 2023 · Completed: Dec 30, 2024
2 conditions1 sponsor27 locations
NCT05878665
Low-dose Contrast Media for Low-kVp Abdomen CT
NARecruiting
292 participants
Started: Dec 21, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location